Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barbier

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Brain, Behavior, and Immunity|January 31, 2021
Toll-like receptor 5 knock-out mice exhibit a specific low level of anxietyA M Hamieh, G Mallaret, M Meleine, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ann J Barbier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis IIJoseph Muenzer, Christian J Hendriksz, Zheng Fan, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2007
Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activityEmily M Stocking, Jennifer M Miller, Ann J Barbier, et al.
Clinical Pharmacology in Drug Development|August 10, 2018
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy VolunteersHua Yang, Elizabeth Merica, Yue Chen, et al.
European Journal of Pharmacology|May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitorLeah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
World Journal of Surgery|September 1, 1996
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine SurgeonsJ L Kraimps, A Denizot, B Carnaille, et al.
British Journal of Pharmacology|October 7, 2004
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonistA J Barbier, C Berridge, C Dugovic, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Brain, Behavior, and Immunity|January 31, 2021
Toll-like receptor 5 knock-out mice exhibit a specific low level of anxietyA M Hamieh, G Mallaret, M Meleine, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ann J Barbier, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis IIJoseph Muenzer, Christian J Hendriksz, Zheng Fan, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2007
Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activityEmily M Stocking, Jennifer M Miller, Ann J Barbier, et al.
Clinical Pharmacology in Drug Development|August 10, 2018
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy VolunteersHua Yang, Elizabeth Merica, Yue Chen, et al.
European Journal of Pharmacology|May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitorLeah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
World Journal of Surgery|September 1, 1996
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine SurgeonsJ L Kraimps, A Denizot, B Carnaille, et al.
British Journal of Pharmacology|October 7, 2004
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonistA J Barbier, C Berridge, C Dugovic, et al.
Pageof 19